← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Neurosigma, Inc.
Los Angeles, CA
$7,391,278
Total funding
5
Grants
Funding over time
peak $1.4M · FY2011–19$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,391,278 · 5
By mechanism
R42$2,949,208 · 1
U44$2,596,921 · 1
R41$1,429,406 · 2
R43$415,743 · 1
Investigators at Neurosigma, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms$1,072,694
R42 · FY2016 · NS
Development of an Implantable Trigeminal Nerve Stimulation System for Drug Resist$1,052,780
U44 · FY2015 · NS
Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms$976,739
R42 · FY2018 · NS
Development of an Implantable Trigeminal Nerve Stimulation System for Drug Resist$925,538
U44 · FY2019 · NS
Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms$899,775
R42 · FY2017 · NS
Trigeminal Nerve Stimulation for Epilepsy$418,261
R41 · FY2011 · NS
Development of an Anti-Embolic Micromesh Carotid Stent$415,743
R43 · FY2018 · HL
Preclinical Testing of a Novel Flow Diverting Stent for the Treatment of Intracra$342,847
R41 · FY2011 · NS
Preclinical Testing of a Novel Flow Diverting Stent for the Treatment of Intracra$339,690
R41 · FY2013 · NS
Trigeminal Nerve Stimulation for Epilepsy$328,608
R41 · FY2012 · NS
Development of an Implantable Trigeminal Nerve Stimulation System for Drug Resist$313,545
U44 · FY2014 · NS
Development of an Implantable Trigeminal Nerve Stimulation System for Drug Resist$305,058
U44 · FY2013 · NS